Now showing items 1-9 of 9

  • Anti-survivin antibody responses in lung cancer 

    Karanikas, V.; Khalil, S.; Kerenidi, T.; Gourgoulianis, K. I.; Germenis, A. E. (2009)
    Existing evidence regarding spontaneous anti-survivin humoral responses in lung cancer is inconclusive. Moreover, despite that cancer cell death elicited by radiotherapy and some chemotherapeutic agents seems to be ...
  • Baseline Insulin-Like Growth Factor-I Plasma Levels, Systemic Inflammation, Weight Loss and Clinical Outcome in Metastatic Non-Small Cell Lung Cancer Patients 

    Vlachostergios, P. J.; Gioulbasanis, I.; Kamposioras, K.; Georgoulias, P.; Baracos, V. E.; Ghosh, S.; Maragouli, E.; Georgoulias, V.; Papandreou, C. N. (2011)
    Background: Cancer patients frequently suffer from weight loss and systemic inflammation in the context of advanced disease, which is related to adverse outcome. Insulin-like growth factor (IGF)-I is an anabolic molecule ...
  • Clinical significance of serum adipokines levels in lung cancer 

    Kerenidi, T.; Lada, M.; Tsaroucha, A.; Georgoulias, P.; Mystridou, P.; Gourgoulianis, K. I. (2013)
    Adipokines have a significant effect on metabolism, immunoinflammatory responses as well as on carcinogenesis; therefore, we aimed at evaluating their potential predictive and prognostic significance in lung cancer. Eighty ...
  • Exophthalmos as a first manifestation of small cell lung cancer: A long-term follow-up 

    Konoglou, M.; Zarogoulidis, P.; Porpodis, K.; Androudi, S.; Papakosta, D.; Matthaios, D.; Kontakiotis, T.; Zervas, V.; Kalaitzidou, E.; Mitrakas, A.; Touzopoulos, P.; Zarogoulidis, K. (2011)
    Small cell lung cancer is characterized by rapid growth and early metastasis. Despite its sensitivity to cytotoxic therapy, until now treatments have failed to control or cure this disease in most patients. Οrbital metastases ...
  • The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer 

    Gioulbasanis, I.; Pallis, A.; Vlachostergios, P. J.; Xyrafas, A.; Giannousi, Z.; Perdikouri, I. E.; Makridou, M.; Kakalou, D.; Georgoulias, V. (2012)
    Purpose: Lung cancer is the most common cause of cancer death. A cumulative prognostic score based on C-reactive protein and albumin, termed the Glasgow Prognostic Score (GPS), indicates the presence of systemic inflammatory ...
  • Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer 

    Karanikas, V.; Zamanakou, M.; Kerenidi, T.; Dahabreh, J.; Hevas, A.; Nakou, M.; Gourgoulianis, K. I.; Germenis, A. E. (2007)
    Background: The expression of indoleamine 2,3-dioxygenase (IDO) by tumor cells has been considered as a major tumor immune escape mechanism. The aim of this study was to investigate the expression of IDO in lung cancer ...
  • Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer 

    Vlachostergios, P. J.; Gioulbasanis, I.; Ghosh, S.; Tsatsanis, C.; Papatsibas, G.; Xyrafas, A.; Hatzidaki, E.; Vasiliou, C.; Kamposioras, K.; Agelaki, S.; Margioris, A. N.; Nasi, D.; Georgoulias, V.; Papandreou, C. N. (2013)
    Cancer patients usually develop malnutrition which may alter their innate immune system integrity. The aim of this study was to investigate the clinical relevance of chemokine response after lipopolysaccharide (LPS)-stimulation ...
  • Respiratory diseases and Helicobacter pylori infection: Is there a link? 

    Roussos, A.; Philippou, N.; Mantzaris, G. J.; Gourgoulianis, K. I. (2006)
    Recent studies suggest an epidemiological association between Helicobacter pylori infection and several extragastroduodenal pathologies, including cardiovascular, rheumatic, skin and liver diseases. The observed associations ...
  • VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer 

    Dalaveris, E.; Kerenidi, T.; Katsabeki-Katsafli, A.; Kiropoulos, T.; Tanou, K.; Gourgoulianis, K. I.; Kostikas, K. (2009)
    The aim of the present study was to evaluate the levels of VEGF, 8-isoprostane and TNF-alpha in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible ...